Showing results (91-100 of 1,146) with videos related to
Sort By:
Pageof 115
Cancer Letters|February 8, 2018
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapyJunjie Wu, David J WaxmanToxicology in Vitro : an International Journal Published in Association with BIBRA|November 19, 2005
Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancerPartha Roy, David J WaxmanObesity Surgery|December 18, 2004
Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three casesJames C BartonToxicology and Applied Pharmacology|May 12, 2023
TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobuleKritika Karri, David J WaxmanArchives of Biochemistry and Biophysics|August 1, 1987
Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonistsL Clarke, D J WaxmanCancer Research|May 1, 1989
Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activationL Clarke, D J WaxmanCancer Surveys|January 1, 1995
Multiple primary cancers in association with prostate cancerH S Pandha, J WaxmanCancer Research|June 5, 2001
Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapyY Jounaidi, D J WaxmanCancer Letters|November 26, 2019
Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma modelsBin Du, David J WaxmanBiochemical Pharmacology|May 26, 1995
Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cellsG Chen, D J WaxmanPageof 115